This time last year almost all of the focus was on the full phase I results. All those months of waiting, only for it to cause the SP to fall. Now all the talk on here seems to be about cardiocel....it's starting to get frustrating holding this stock, especially when another promising small cap that motley were sprucing (NEA) is doing so well.
- Forums
- ASX - By Stock
- AHZ and HSV
This time last year almost all of the focus was on the full...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $46.16K | 2.581K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 122 | $17.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.91 | 32 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 122 | 17.800 |
1 | 631 | 17.710 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 26 | 17.570 |
Price($) | Vol. | No. |
---|---|---|
17.910 | 32 | 2 |
17.930 | 51 | 2 |
17.940 | 12 | 2 |
17.950 | 270 | 2 |
18.000 | 518 | 2 |
Last trade - 13.54pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online